These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands. Sun YT; Wang GF; Yang YQ; Jin F; Wang Y; Xie XY; Mach RH; Huang YS Eur J Med Chem; 2018 Mar; 147():227-237. PubMed ID: 29438891 [TBL] [Abstract][Full Text] [Related]
7. Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands. van Waarde A; Rybczynska AA; Ramakrishnan N; Ishiwata K; Elsinga PH; Dierckx RA Curr Pharm Des; 2010; 16(31):3519-37. PubMed ID: 21050178 [TBL] [Abstract][Full Text] [Related]
8. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy. Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687 [TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and cytotoxic effects of some sigma2 agonists and sigma1 antagonists in tumour cell lines. Colabufo NA; Berardi F; Contino M; Niso M; Abate C; Perrone R; Tortorella V Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):106-13. PubMed ID: 15322732 [TBL] [Abstract][Full Text] [Related]
10. Insights in Organometallic Synthesis of Various Adamantane Derivatives with Sigma Receptor-Binding Affinity and Antiproliferative/Anticancer Activity. Papanastasiou I Methods Mol Biol; 2018; 1824():279-286. PubMed ID: 30039413 [TBL] [Abstract][Full Text] [Related]
11. Molecular Probes for Imaging the Sigma-2 Receptor: In Vitro and In Vivo Imaging Studies. Zeng C; McDonald ES; Mach RH Handb Exp Pharmacol; 2017; 244():309-330. PubMed ID: 28176045 [TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors. Zampieri D; Romano M; Fortuna S; Amata E; Dichiara M; Cosentino G; Marrazzo A; Mamolo MG Molecules; 2024 Jun; 29(11):. PubMed ID: 38893570 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents. Rui M; Rossi D; Marra A; Paolillo M; Schinelli S; Curti D; Tesei A; Cortesi M; Zamagni A; Laurini E; Pricl S; Schepmann D; Wűnsch B; Urban E; Pace V; Collina S Eur J Med Chem; 2016 Nov; 124():649-665. PubMed ID: 27614411 [TBL] [Abstract][Full Text] [Related]
14. Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer. Azzariti A; Colabufo NA; Berardi F; Porcelli L; Niso M; Simone GM; Perrone R; Paradiso A Mol Cancer Ther; 2006 Jul; 5(7):1807-16. PubMed ID: 16891467 [TBL] [Abstract][Full Text] [Related]
15. 1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and human Δ(8)-Δ(7) sterol isomerase ligands with antiproliferative and P-glycoprotein inhibitory activity. Abate C; Niso M; Contino M; Colabufo NA; Ferorelli S; Perrone R; Berardi F ChemMedChem; 2011 Jan; 6(1):73-80. PubMed ID: 21069657 [TBL] [Abstract][Full Text] [Related]
16. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. Hashimoto K; Ishiwata K Curr Pharm Des; 2006; 12(30):3857-76. PubMed ID: 17073684 [TBL] [Abstract][Full Text] [Related]
17. Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations. Abate C; Niso M; Berardi F Future Med Chem; 2018 Aug; 10(16):1997-2018. PubMed ID: 29966437 [TBL] [Abstract][Full Text] [Related]
18. Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer. Pati ML; Hornick JR; Niso M; Berardi F; Spitzer D; Abate C; Hawkins W BMC Cancer; 2017 Jan; 17(1):51. PubMed ID: 28086830 [TBL] [Abstract][Full Text] [Related]